Use of tiotropium in patients with COPD aged 80 years and older
Authors:
Open Access
- 15 January 2013
- journal article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 5 (4) , 997-1000
Abstract
The purpose of this study was to examine clinical features and treatment modality approaches in patients with chronic obstructive pulmonary disease (COPD), particularly in those aged 80 years and older. Using databases available at Mito Kyodo General Hospital (Japan), the medical records of COPD patients between April 2009 and December 2011 were retrospectively reviewed. The patient population was divided into three age groups; less than 70 years (the <70 age group), between 70-79 years (the 70-79 age group) and 80 years or older (the ≥80 age group). Demographic data, as well as the efficacy and safety of tiotropium, were compared between the three groups. Patients in the ≥80 age group comprised 35.6% of the study population with COPD (n=174). The ≥80 and 70-79 age groups demonstrated a higher proportion of comorbid disease compared with the <70 age group. A subjective improvement of dyspnea on effort as well as no additional adverse effects were observed in the ≥80 age group, similar to the other two age groups. However, higher incidence of acute exacerbation of COPD in patients aged ≥80 years old was found, particularly in those with comorbid disease. The efficacy and safety of tiotropium in COPD patients in the ≥80 age group were almost identical to patients <80 years old, however, physicians must be cautious with acute exacerbation of COPD in the extremely elderly population with comorbid disease.Keywords
This publication has 15 references indexed in Scilit:
- Tiotropium Bromide Inhalation PowderDrugs, 2012
- Comorbidities of chronic obstructive pulmonary diseaseCurrent Opinion in Pulmonary Medicine, 2011
- Tiotropium 5 μg via Respimat and 18 μg via HandiHaler; efficacy and safety in Japanese COPD patientsRespiratory Medicine, 2010
- Quality of COPD care in hospital outpatient clinics in Denmark: The KOLIBRI studyRespiratory Medicine, 2009
- Prognosis of primary care patients aged 80 years and older with lower respiratory tract infectionBritish Journal of General Practice, 2009
- Future Treatments for Chronic Obstructive Pulmonary Disease and Its ComorbiditiesProceedings of the American Thoracic Society, 2008
- Global burden of COPD: risk factors, prevalence, and future trendsThe Lancet, 2007
- Pooled Clinical Trial Analysis of Tiotropium SafetyChest, 2006
- A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 2002
- Tiotropium (SPIRIVA™): Mechanistical considerations and clinical profile in obstructive lung diseaseLife Sciences, 1999